ArticleOpen forum infectious diseases2019

Randomized Trial of Ceftazidime-Avibactam vs Meropenem for Treatment of Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (REPROVE): Analyses per US FDA-Specified End Points.

Antoni Torres et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.